PDT Partners’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $656K | Sell |
86,752
-19,448
| -18% | -$147K | 0.04% | 487 |
|
|
2025
Q1 | $586K | Buy |
106,200
+72,751
| +217% | +$402K | 0.04% | 496 |
|
|
2024
Q4 | $192K | Buy |
33,449
+107
| +0.3% | +$615 | 0.02% | 660 |
|
|
2024
Q3 | $345K | Sell |
33,342
-2,901
| -8% | -$30.1K | 0.03% | 578 |
|
|
2024
Q2 | $470K | Sell |
36,243
-3,484
| -9% | -$45.2K | 0.04% | 477 |
|
|
2024
Q1 | $694K | Sell |
39,727
-23,498
| -37% | -$410K | 0.07% | 398 |
|
|
2023
Q4 | $595K | Sell |
63,225
-4,093
| -6% | -$38.5K | 0.07% | 375 |
|
|
2023
Q3 | $752K | Buy |
67,318
+39,699
| +144% | +$443K | 0.09% | 350 |
|
|
2023
Q2 | $591K | Buy |
+27,619
| New | +$591K | 0.08% | 354 |
|
|
2022
Q3 | – | Sell |
-11,597
| Closed | -$548K | – | 907 |
|
|
2022
Q2 | $548K | Buy |
+11,597
| New | +$548K | 0.05% | 572 |
|
|
2021
Q4 | – | Sell |
-12,954
| Closed | -$736K | – | 905 |
|
|
2021
Q3 | $736K | Sell |
12,954
-9,946
| -43% | -$565K | 0.05% | 401 |
|
|
2021
Q2 | $1.01M | Buy |
22,900
+3,137
| +16% | +$138K | 0.07% | 378 |
|
|
2021
Q1 | $975K | Sell |
19,763
-4,137
| -17% | -$204K | 0.07% | 376 |
|
|
2020
Q4 | $1.01M | Buy |
23,900
+4,500
| +23% | +$189K | 0.07% | 322 |
|
|
2020
Q3 | $888K | Sell |
19,400
-9,542
| -33% | -$437K | 0.06% | 327 |
|
|
2020
Q2 | $1.45M | Buy |
+28,942
| New | +$1.45M | 0.1% | 237 |
|
|
2015
Q4 | – | Sell |
-13,485
| Closed | -$487K | – | 561 |
|
|
2015
Q3 | $487K | Buy |
13,485
+7,243
| +116% | +$262K | 0.01% | 908 |
|
|
2015
Q2 | $281K | Sell |
6,242
-7,826
| -56% | -$352K | 0.01% | 1150 |
|
|
2015
Q1 | $431K | Buy |
+14,068
| New | +$431K | 0.01% | 1067 |
|
|
2014
Q4 | – | Sell |
-36,096
| Closed | -$1.43M | – | 764 |
|
|
2014
Q3 | $1.43M | Buy |
+36,096
| New | +$1.43M | 0.04% | 520 |
|